The translational control of oncoprotein expression is implicated in many cancers. Here we report an eIF4A RNA helicase-dependent mechanism of translational control that contributes to oncogenesis and underlies the anticancer effects of silvestrol and related compounds. For example, eIF4A promotes T-cell acute lymphoblastic leukaemia development in vivo and is required for leukaemia maintenance. Accordingly, inhibition of eIF4A with silvestrol has powerful therapeutic effects against murine and human leukaemic cells in vitro and in vivo. We use transcriptome-scale ribosome footprinting to identify the hallmarks of eIF4A-dependent transcripts. These include 59 untranslated region (UTR) sequences such as the 12-nucleotide guanine quartet (CGG) 4 motif that can form RNA G-quadruplex structures. Notably, among the most eIF4A-dependent and silvestrol-sensitive transcripts are a number of oncogenes, superenhancer-associated transcription factors, and epigenetic regulators. Hence, the 59 UTRs of select cancer genes harbour a targetable requirement for the eIF4A RNA helicase.
The translational control of oncoprotein expression is implicated in many cancers. Here we report an eIF4A RNA helicase-dependent mechanism of translational control that contributes to oncogenesis and underlies the anticancer effects of silvestrol and related compounds. For example, eIF4A promotes T-cell acute lymphoblastic leukaemia development in vivo and is required for leukaemia maintenance. Accordingly, inhibition of eIF4A with silvestrol has powerful therapeutic effects against murine and human leukaemic cells in vitro and in vivo. We use transcriptome-scale ribosome footprinting to identify the hallmarks of eIF4A-dependent transcripts. These include 59 untranslated region (UTR) sequences such as the 12-nucleotide guanine quartet (CGG) 4 motif that can form RNA G-quadruplex structures. Notably, among the most eIF4A-dependent and silvestrol-sensitive transcripts are a number of oncogenes, superenhancer-associated transcription factors, and epigenetic regulators. Hence, the 59 UTRs of select cancer genes harbour a targetable requirement for the eIF4A RNA helicase.
The activation of translation contributes to malignant transformation and is an emerging target for cancer therapies 1,2 . For example, oncogenic RAS, ERK and AKT stimulate cap-dependent translation via mTORC1 and the eIF4E-binding protein (4E-BP) 3 . The initiation of cap-dependent translation involves a tightly controlled multi-protein initiation complex 4 . This includes the cap-binding protein eIF4E, which is abundantly expressed in cancer and can transform fibroblasts and promote tumour development in vivo 1, [5] [6] [7] [8] . Another key factor is the eIF4A RNA helicase, which has a role in scanning the messenger RNA 59 UTR for a translation start site and has been implicated in the translation of mRNAs with long and complex 59 UTRs 9 . EIF4A is the molecular target for three distinct natural compounds-silvestrol, hippuristanol and pateamine A-and these compounds show promising anticancer activity 10, 11 . Recent studies have defined the helicase action of eIF4A, as well as its protein interactions 12 , and revealed eIF4A to have a role in microRNA action 13 . Exactly how eIF4A affects translation and which specific mRNA features necessitate its helicase activity have not been defined.
Ribosome footprinting provides a snapshot of translation across the transcriptome 14 . It uses deep sequencing to identify ribosome-protected RNA fragments and compare them to total transcript levels. Among the various applications of this technology, the most relevant to this study concern the translational effects of mTORC1 inhibition 15, 16 . We use ribosome footprinting to identify eIF4A-dependent transcripts and their hallmark features.
eIF4A is an oncogene in T-ALL NOTCH-driven T-cell acute lymphoblastic leukaemia (T-ALL) exemplifies the activation of AKT/mTORC1 and cap-dependent translation in cancer. In 36 paediatric T-ALL samples we find PTEN mutations (14%) and deletions (11%) 17 , NOTCH1 mutations (56%) 18 and an IL7R mutation (3%) 19 (Extended Data Fig. 1a-c and Supplementary Table 1 ). These genetic lesions promote T-ALL development in a murine T-ALL model (Fig. 1a) 20 . Notch causes T-ALL with a mean latency of 91.5 days (n 5 14), knockdown of Pten or expression of the mutant Il7r/p.Leu242_ Leu243insAsnProCys accelerates disease onset (Pten, 47.1 days, n 5 10, P , 0.0001; Il7r, 35.5 days, n 5 4, P , 0.0001). Remarkably, expression of eIF4E or eIF4A1 similarly accelerates leukaemia development (eIF4E, 30.75 days, n 5 4, P , 0.0001; eIF4A1, 33.8 days, n 5 5, P , 0.0001) ( Fig. 1b and Extended Data Fig. 1d ). All T-ALLs are CD4/CD8 double positive, and increased ribosomal S6 phosphorylation indicates mTORC1 activation in Pten-deficient and Il7r-expressing T-ALLs (Extended Data Fig. 1d , f-i). EIF4E and eIF4A1 are required to maintain T-ALL and cells expressing a constitutive 4E-BP1-encoding allele (4E-BP1(4A)) 21 or an eIF4A1 knockdown construct are rapidly eliminated from mixed populations (Fig. 1c, d and Extended Data Fig. 1e ) (P 5 0.000002, vector versus 4E-BP1(4A); P 5 0.000008, vector versus short hairpin RNA (shRNA)-targeted eIF4A (sheIF4A)).
Silvestrol and a synthetic analogue, (6)-CR-31-B, inhibit eIF4A1/2 (Extended Data Fig. 2a, b) 11, 22 . A reporter assay confirms that both drugs preferentially block cap-dependent translation of Renilla luciferase compared to firefly luciferase expressed from the hepatitis C virus (HCV) internal ribosome entry site (IRES) ( Fig. 2a and Extended Data Fig. 2c ). Silvestrol induces cell death in primary human T-ALL samples, cell lines, and murine T-ALLs at nanomolar half-maximum inhibitory concentration (IC 50 ) values ( Fig. 2b and Extended Data Fig. 2d, e ). In vivo, silvestrol is effective against murine or xenografted T-ALLs ( Fig. 2c and Extended Data Fig. 2f-h) . In KOPT-K1 tumour-bearing (,1 cm 3 ) NOD/SCID mice, treatment with silvestrol (0.5 mg kg 21 , intraperitoneal (i.p.), days 0-6, n 5 7, P , 0.001) or (6)-CR-31-B (0.2 mg kg 21 , i.p., days 0-6, n 5 8, P , 0.001) delays tumour growth, and causes apoptosis and cell cycle arrest (Fig. 2c, d and Extended Data Fig. 2g , h). Detailed toxicology shows that this treatment is well-tolerated in mice (Extended Data Fig. 3a -j and Supplementary Table 2 ). Rapamycin induces an S6 kinase-dependent feedback activation of AKT (T308) 23 ; by contrast, silvestrol or (6)-CR-31-B does not trigger this response in KOPT-K1 cells ( Fig. 2e, f ). This result implies that inhibition of eIF4A is effective without having an effect on S6 kinase.
Ribosome footprinting
For footprinting studies, we treated KOPT-K1 cells with 25 nM of silvestrol or vehicle for 45 min, then deep-sequenced total RNA and ribosomeprotected RNA (Fig. 3a) 14 . We removed reads mapping to ribosomal RNAs, non-coding RNAs, library linkers and incomplete alignments (Extended Data Fig. 4a, b ). The majority of the remaining reads between 25-35 nucleotides in length mapped to protein-coding genes (Extended Data Fig. 4c, d) . The total number of ribosome footprint reads that mapped to exons was 3.2 million in control-treated and 3.4 million in silvestrol-treated samples, and this corresponded to ,11,128 proteincoding genes. Ribosome footprint reads showed a wider variation between control and silvestrol groups than the total RNA sequences, indicating minimal transcriptional variation (Extended Data Fig. 4e ). The number of ribosomes occupying any transcript is given as genespecific ribosome footprint reads per one million total reads (RPM). The RPM frequency distribution in control and silvestrol samples was overlapping, indicating that silvestrol equally affected mRNAs with high 
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and low ribosome occupancy (Extended Data Fig. 4f ). Polysome analysis and metabolic labelling with L-azidohomoalanine (AHA) confirmed an inhibitory effect on translation (AHA: silvestrol ,60%, P 5 3.6 3 10 23 , silvestrol versus vehicle; cycloheximide 80%, P 5 2 3 10 24 , cycloheximide versus vehicle) (Extended Data Fig. 4g , h). The translational efficiency (TE) for each mRNA is calculated by normalizing the ribosome footprint frequency to transcript length and total transcript abundance (reads per kilobase per million reads (RPKM)). RPKM values for ribosome footprints from vehicle and silvestrol samples were correlated (R 2 5 0.94), indicating an overall inhibitory effect (Extended Data Fig. 4i ).
We developed the differential-expression-normalized ribosome occupancy (DERseq; based on DEXseq 24 ) algorithm to identify mRNAs that were most strongly affected by silvestrol. We used a cut-off at P , 0.03 (Z-score . 2.5) to define groups of mRNAs whose translational efficiency was the most (TE down; red) or least (TE up; blue) affected by silvestrol compared to background (grey) ( Fig. 3b and Supplementary Table 3a -c). The TE down group includes 281 mRNAs (220 with annotated 59 UTRs), TE up includes 190 mRNAs, and the background list includes 2,243 mRNAs. The footprinting methodology also provides positional information and the rDiff algorithm identifies mRNAs with significant shifts in ribosome footprint distribution 25 . For example, silvestrol caused an accumulation of ribosome footprints in the 59 UTR of 847 proteincoding transcripts (rDiff positive genes; 641 with annotated 59 UTRs, P , 0.001) ( Supplementary Table 3d ). Sixty-two transcripts showed both decreased TE and altered ribosome footprint distribution, whereas we observed no change in distribution among TE up genes ( Fig. 3c , Extended Data Fig. 5a -c and Supplementary Table 3e ).
The (CGG) 4 motif marks eIF4A-dependent mRNAs
We compared the TE up, TE down and background groups (Supplementary Table 3a -c), and confirm that mRNAs with longer 59 UTRs were significantly enriched in the TE down group (mean UTR length, 368 nucleotides in TE down; 250 nucleotides in background, P 5 7.6 3 10 212 , silvestrol versus control, by two-sample Kolmogorov-Smirnov) (Fig. 3d ). The TE up group showed no difference in 59 UTR length (265 nucleotides; P 5 0.165, silvestrol versus control) (Extended Data Fig. 4j ). We found no predilection for known regulatory elements in the TE down group; these included TOP 26 , TOP-like sequences 15 , IRES 27 and pyrimidine-rich translational elements (PRTEs) 26 (Fig. 3e ). The TE up group showed the expected enrichment in IRES elements (Extended Data Fig. 4k ). Using the DREME algorithm 28 ,we found a striking enrichment of a 12-nucleotide (CGG) 4 motif and related but shorter 9-nucleotide motifs among the 220 TE down genes ( Fig. 3f , g and Supplementary Table 4a , b). Both the 12-nucleotide and 9-nucleotide motifs were significantly enriched over background and their frequency was significantly higher than expected merely by the longer UTR length (P , 2.2 3 10 216 , one-sided binomial test) ( Fig. 3h ). We found no enriched motif in the TE up group. Transcripts with an altered ribosome footprint distribution (rDiff positive) showed similar features. These included longer 59 UTRs (rDiff, mean 271 nucleotides versus background: mean 230 nucleotides; P 5 0.004) (Extended Data Fig. 5d ) and absence of enrichment for TOP, TOP-like, PTRE or IRES elements (Extended Data Fig. 5e ). Notably, we again identified the 12-nucleotide motif seen in the TE analysis but shifted by one nucleotide (Extended Data Fig. 5f and Supplementary Table 4c ), along with 9-nucleotide variants, highly significantly enriched in the rDiff positive set compared to background (P 5 2.2 3 10 216 ) (Extended Data Fig. 5g and Supplementary Table 4d ).
The (CGG) 4 motif corresponds to G-quadruplexes
We noticed that in many instances the 59 UTR motifs coincided with computationally predicted G-quadruplex structures 29 . For example, 51% of the 12-nucleotide (CGG) 4 sequences and 43% of the most common 9-nucleotide motifs localized precisely to the G-quadruplex structuresthe ADAM10 59 UTR provides an example ( Fig. 4a , b, Extended Data Fig. 6a and Supplementary Table 4e -k). G-quadruplex structures form by non-Watson-Crick interactions between paired guanine quartets connected by at least one linker nucleotide (A or C) in a parallel or antiparallel orientation. Accordingly, G-quadruplex structures were significantly enriched among TE down genes and 79 of 220 TE down transcripts harboured at least one G-quadruplex (P 5 2 3 10 211 ) ( Fig. 4a-c and Supplementary Table 4e -k).
We confirmed by circular dichroism that the 12-nucleotide and extended 9-nucleotide sequence motifs form G-quadruplexes. Briefly, we compared the molar ellipticity of RNA oligomers encoding the 12nucleotide and the 9-nucleotide motifs to a known G-quadruplex element in human telomeric RNA 30 and a randomly organized oligomer with equal GC content and length. The 9-nucleotide sequences included either two (oligonucleotide 1) or five (oligonucleotide 2) flanking nucleotides as seen in the 59 UTRs of MTA2, TGFB1, MAPKAP1 and 
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ADAM10 (Supplementary Table 5 ). The human telomeric sequence, the 12-nucleotide motif, and the 9-nucleotide motifs showed typical positive and negative molar ellipticity peaks at 264 nm and 240 nm, indicating parallel G-quadruplex structures. By contrast, the random oligomer had a shift in peak wavelengths (270 and 233 nm) ( Fig. 4d , e and Extended Data Fig. 6b ). This effect was dependent on the presence of potassium and was abrogated in sodium phosphate buffer without potassium (Extended Data Fig. 6c ). Circular dichroism combined with thermal unfolding revealed that under potassium conditions the melting temperature for the 12-nucleotide motif was higher (56 uC) than the random oligomer (49 uC), corresponding to a free energy difference of 232 kcal mol 21 (Fig. 4f) . Similarly, computational modelling of complete 59 UTRs with increasing numbers of motifs showed a decrease of the predicted minimum free energy when the 59 UTR is allowed to fold into G-quadruplexes ( Fig. 4g ). Hence, the 12-nucleotide and some of the 9-nucleotide motifs can form energetically favourable G-quadruplex structures (Fig. 4h ).
Next, we tested the 12-nucleotide (CGG) 4 motif in a translation assay. We constructed a reporter system to compare four 12-nucleotide motifs in tandem (G-quadruplex construct) to a random sequence of equal length and GC content (control construct), using IRES firefly luciferase as an internal control ( Fig. 4i ). Treatment with silvestrol (25 nM) reduced the translation of the G-quadruplex construct and did not affect the control construct. Hippuristanol and pateamine A had identical effects (Extended Data Fig. 6d ), whereas cycloheximide (20 nM) suppressed both reporters (Fig. 4j, k) . Other RNA helicases (DHX9, DHX36) may resolve G-quadruplex structures 30, 31 . However, we find predominant expression of eIF4A2 in T-ALL 32 , and knockdown confirms an eIF4Adependent effect on the G-quadruplex reporter ( Fig. 4l and Extended Data Fig. 6e ). Conversely, increased expression of eIF4A or a silvestrolbinding-site mutant of eIF4A (P159Q) 33 renders the G-quadruplex reporter insensitive to silvestrol (Extended Data Fig. 6f ). Hence, eIF4A is limiting for the translation of mRNAs harbouring G-quadruplexes in their 59 UTRs.
Transcripts affected by silvestrol
The silvestrol-sensitive transcripts (TE down and rDiff gene lists) include many genes with known roles in T-ALL ( Fig. 5a, b ). The individual ribosome footprint distribution graphs (normalized for mean ribosome footprint count and gene length) illustrate recurrent patterns and also variations (Extended Data Fig. 7a ). For example, the MYC, MDM2 and RUNX1 transcripts harbour multiple motifs in their 59 UTRs that correspond to peaks in ribosome footprint density, whereas housekeeping genes show no changes in ribosome footprint profiles. Gene ontology reveals a preponderance of transcription factors and oncogenes, but also some tumour suppressors (Extended Data Fig. 7b ). Furthermore, we note a significant enrichment of superenhancer-associated genes 34 -mostly transcription factors like NOTCH1, MYC, MYB, ETS1 and others ( Fig. 5c , Extended Data Fig. 7c and Supplementary Table 6 ).
We confirmed the effects of silvestrol (25 nM for 24 h) on key target proteins ( Fig. 5d and Extended Data Fig. 7a ). The effect on the MYC protein was especially striking; it lasted for up 48 h, and was readily 
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detected in xenografts in vivo (Fig. 5d-f and Extended Data Fig. 8a, b) . The corresponding mRNAs were unchanged, and the increase in MYC mRNA may reflect a known auto-regulatory mechanism 35 (Extended Data Fig. 8c ). To test which proteins account for silvestrol's effects, we expressed several candidate genes and green fluorescent protein (GFP) in an eIF4A-independent manner from the HCV IRES. In mixed populations of transduced and parental murine leukaemic cells (see Fig. 1c ), we found that individually genes were not protective, whereas coexpression of IRES-MYC and IRES-BCL2 afforded significant protection ( Fig. 5g and Extended Data Fig. 8d-g) . This result indicates that silvestrol kills cancer cells by disrupting the translation of several critical factors.
A selective mechanism of translational control
We report an eIF4A-dependent mechanism of translational control that is encoded in the 59 UTR of susceptible transcripts (Fig. 5h ). The eIF4A RNA helicase has been implicated in the translation of mRNAs with long and complex 59 UTRs 9 . Ribosome footprinting technology allowed us to identify silvestrol-sensitive mRNAs and analyse their hallmark features. Besides 59 UTR length, these included a 12-nucleotide (CGG) 4 motif, additional 9-nucleotide motifs, and computationally predicted G-quadruplex structures that correspond to the motif. RNA G-quadruplexes are energetically favourable/stable RNA structures made from at least two stacks of four guanosines with non-Watson-Crick interactions (Hoogsteen hydrogen bonds) with intervening linker nucleotides 29 . The minimum number is 12 nucleotides-for example, the 12-nucleotide motif (CGG) 4 -but shorter 9-nucleotide motifs can include neighbouring nucleotides to complete the structure. Frequently, more than 12 nucleotides contribute to G-quadruplexes, and typically silvestrol-sensitive transcripts harbour several G-quadruplexes in their 59 UTRs. These features define a specific subset of genes whose translation requires eIF4A and that is clearly distinct from mTORC1-dependent translation 15, 16 . Many transcription factors and oncogenes require eIF4A for translation. G-quadruplex structures have been observed, for example, in the NRAS and VEGFA mRNAs [36] [37] [38] , and computational predictions have suggested a broader role in translational regulation 39 . Our results identify a broad set of eIF4A-sensitive transcripts including many oncogenes and transcriptional regulators (for example, MYC, MYB, NOTCH, CDK6, BCL2, and others). We can speculate that this mechanism provides additional control over these genes. In this regard, we note that a recent study identified a role for eIF4A2 in microRNA function and reports that eIF4A-sensitive transcripts are probably controlled by microRNAs 13 . We further find a significant overlap with genes whose transcription is controlled by superenhancers 34 .
Our study provides new insight into the striking anticancer effect of silvestrol and related compounds. Several strategies are available to target oncoprotein translation (for example, mTORC inhibitors 15 , the eIF4G inhibitory peptide 4EGI-1 (ref. 40 ), or ribavirin 41 ). We find that eIF4A has an oncogenic activity that is required for the expression of key oncogenes. Accordingly, silvestrol can obliterate oncoproteins including MYC, NOTCH, BCL2, and others. This finding suggests potential activity in other cancers as a single agent or in combination with other drugs.
METHODS SUMMARY
Ribosome footprinting. KOPT-K1 cells were treated with silvestrol (25 nM) or DMSO for 45 min, followed by cycloheximide treatment for 10 min. Total RNA and ribosome-protected fragments were isolated following a published protocol 14 . Deep sequencing libraries were generated from these fragments and sequenced on the HiSeq 2000 platform. Genome annotation was from the GENCODE project (http://www.gencodegenes.org/releases/14.html). Ribosome footprint intensity (RPM) and the expression value (RPKM) were measured from total mRNA-sequencing data and translation values were measured from ribosome footprint data. To evaluate the TE change between silvestrol-and vehicle-treated samples, we then calculated TE 5 RPKM footprint /RPKM mRNA (ref. 15) . Changes in ribosome footprint profiles were determined using the DEXseq algorithm 24 .
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. . Fig. 1c, d) showing the percentage of each starting GFP-positive population of murine T-ALL cells partially transduced with the indicated constructs and treated with silvestrol (Silv.). *P , 0.05, n 5 3 biological replicates, error bars indicate standard deviation. h, Diagram showing an eIF4A-dependent mechanism of translational control. RF, ribosome footprint.
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METHODS
Ribosome footprinting. KOPT-K1 cells were treated with silvestrol (25 nM) or DMSO for 45 min, followed by cycloheximide treatment for 10 min. Total RNA and ribosome-protected fragments were isolated following a published protocol 14 . Deep sequencing libraries were generated from these fragments and sequenced on the HiSeq 2000 platform. Genome annotation was from the GENCODE project (http://www.gencodegenes.org/releases/14.html). Ribosome footprint intensity (RPM) and the expression value (RPKM) were measured from total mRNA-sequencing data and translation values were measured from ribosome footprint data. To evaluate the TE change between silvestrol-and vehicle-treated samples, we then calculated TE 5 RPKM footprint /RPKM mRNA (ref. 15) . Changes in ribosome footprint profiles were determined using the DEXseq algorithm 24 . Metabolic labelling of nascent protein. KOPT-K1 cells were labelled for nascent protein synthesis using Click-iT R AHA metabolic labelling reagent obtained from Invitrogen (catalogue no. C10102) as per the manufacturer's instructions. Briefly, following silvestrol, cycloheximide or DMSO treatment, cells were incubated in methionine-free medium for 30 min before AHA labelling for 1 h. Cells were fixed with 4% paraformaldehyde in PBS for 15 min, permeabilized with 0.25% Triton X-100 in PBS for 15 min followed by one wash with 3% BSA. Cells were then stained using Alexa Fluor 488 Alkyne (Invitrogen catalogue no. A10267) with Click-iT Cell reaction Buffer Kit (Invitrogen catalogue no. C10269). Changes in mean fluorescence intensity as a measure of newly synthesized protein were detected by flow cytometric analysis. Polysome profiling. KOPT-K1 cells were treated with silvestrol or DMSO for 45 min, followed by cycloheximide treatment for 10 min. Cell pellet was lysed in polysome lysis buffer (300 mM NaCl, 15 mM Tris-HCl (pH 7.5), 15 mM MgCl 2 , 1% Triton X-100, 0.1 mg ml 21 cycloheximide, 1 mg ml 21 heparin). Polysome fractions were isolated using 4 ml 10-50% sucrose density gradients (300 mM NaCl, 100 mM MgCl 2 , 15 mM Tris-HCl (pH 7.5), 1 mg ml 21 cycloheximide, 10 mg ml 21 heparin). Gradients were centrifuged in an SW40Ti rotor at 35,000 r.p.m. for 2 h. Fractions of 100 ml were collected manually from the top, and optical density (OD) at 254 nm was measured. Sequence alignment. The human genome sequence hg19 was downloaded from the UCSC public database (http://hgdownload.cse.ucsc.edu/goldenPath/hg19/ chromosomes). Ribosome footprint (RF) reads were aligned to reference genome hg19 using PALMapper 42 . PALMapper clips the linker sequence (59-CTGTAGG CACCATCAAT-39), which is technically introduced during RF library construction, and trims the remaining sequence from the 39 end while aligning the reads to reference sequence. Briefly, we set the parameters for PALMapper as follows: maximum number of mismatches: 2; maximum number of gaps: 0; minimum aligning length: 15; maximum intron length (splice alignment): 10,000; minimum length of a splicing read aligned to either side of the intron boundary: 10. We only use the uniquely aligned reads for further analysis.
To remove ribosome RNA contamination, the footprint reads were also aligned to a ribosome sequence database using PALMapper with the same parameters except allowing splice alignment. We retrieved the human ribosome sequences from BioMart Ensembl 43 and SILVA 44 databases and merged the results into a single FASTA file, which was used as reference sequence to align against. The rRNAaligned reads were filtered out from hg19-aligned reads.
After removing the rRNA contamination, we still observed a portion of reads that were dominated by linker sequence and Illumina P7 adaptor. These reads can also be trimmed during mapping and cause false alignment. Therefore, we searched a string of 1 to ,8 nucleotides from the linker sequence around the trimming site (62 bp) allowing a 1 nucleotide mismatch. We removed the read if there was no such linker sequence. Finally, we filtered out reads #24 bp and $36 bp, and the remaining reads with an aligned length from 25 to 35 bp were used to analyse the translational effects of silvestrol.
Total mRNA sequencing reads were aligned to the hg19 reference using STAR 45 . We performed the splice alignment and only use the uniquely aligned reads with a maximum of three mismatches. rRNA contaminating reads were also filtered out using the same strategy described earlier. Out of six measurements we removed two outliers and the remaining two biological replicates showed excellent consistency (control, R 2 5 0.90; silvestrol, R 2 5 0.88; data not shown). Footprint profile analysis. For each gene, we only counted the number of aligned reads that were mapped within exonic regions. Genome annotation was downloaded from the GENCODE project (http://www.gencodegenes.org/releases/14.html). Ribosome footprint intensity (RPM) was calculated as RPM 5 C i /(N/10 6 ), where C i is the read count for gene i, and N is the library size of silvestrol-or vehicletreated samples. In order to eliminate the effluence of rRNA contamination, the library size was calculated after read filtering. Similarly, the expression value measured from the total mRNA-seq data and the translation value measured from ribosome footprint data (both in RPKM) were calculated as RPKM 5 C i /(K i 3 N/10 6 ), where K i is the non-overlapped exonic region of each gene. To evaluate the TE change between silvestrol-and vehicle-treated samples, we then calculated TE 5 RPKM footprint /RPKM mRNA as done recently 15 .
To detect the genes for which the ribosome footprint profiles were significantly changed between the silvestrol-treated sample and control, we used DEXseq 24 to perform the statistical test. DEXseq accounts for the discrete nature of the read counts and it also models the biological variability, which has been demonstrated in other applications to be crucial to avoid a great number of false positives. Here, DEXseq was used in a specific way: we fitted the footprint and mRNA-seq read counts into the DEXseq framework, in which silvestrol treatment and control are two biological conditions, and we tested whether the footprint (consisting of two replicates for each condition) and mRNA-seq (we split the three replicates and recombined them into two combinations such that each of them consists of two replicates) read counts were significantly different in the two conditions. The log-ratio of normalized read counts of the silvestrol-treated sample to control indicated whether the ribosome footprint profile was increased or decreased. In the end, we plotted the ratio of TE silvestrol /TE control of all the genes and colour-highlighted them according to the statistical significance of the DEXseq test.
In addition to studying the TE, we also evaluated the ribosomal distribution change between the silvestrol-treated sample and the control. First, a BED file containing all non-overlapping exonic regions was generated based on genome annotation. Then the BED file and footprint BAM files were given as an input to SAMTOOLS 46 to generate new BAM files only including exonic alignment. We input the exonic BAM files of two conditions to rDiff 25 to identify genes that had a significant change in ribosomal distribution. In detail, we performed a nonparametric test implemented in rDiff to detect differential read densities. rDiff takes relevant read information, such as the mapping location and the read structure, to measure the significance of changes in the read density within a given gene between two conditions. The minimal read length was set to 25 bp, and number of permutations was set to 10,000.
To plot the ribosomal distribution curves for multiple genes, we normalized read coverage of each transcript by the mean coverage value of that particular transcript. Then the UTR and coding exon length were normalized in proportion to the overall average length of corresponding regions of a group of genes. Finally all the normalized transcripts were averaged together in a vectored way to plot the coverage distribution. The ribosomal distribution curves for a single gene were plotted in a similar way but without normalizing the read coverage, and the coverage was smoothed using 'moving average' smoothing algorithm. Motif analysis. The transcripts of each gene were quantified based on the total mRNA-seq data using MISO 47 . The 59 UTR of the most abundant transcript was collected for predicting motifs. Both the significant genes with increased or decreased TE and altered ribosomal distribution and the corresponding background gene sets were predicted by DREME 28 . Over-and underrepresented motifs were determined with three different settings: searching for motifs with a length greater than or equal to 6, 9 and 12 bp. We considered the predicted consensus sequences with P , 1 3 10 24 as significant motifs. Motif occurrences were called using FIMO 48 with default parameters for strand specific prediction. P values for the enrichment of motifs in G-quadruplexes (GQs) were calculated using a one-sided binomial test and account for UTR length. The secondary structure of different gene sets was predicted using RNAfold 49 based on the same 59 UTR prepared before. 59 UTR sequences for each respective group of targets were subjected to motif prediction using the program RegRNA (http://regrna.mbc.nctu.edu.tw/html/ prediction.html) and we looked specifically for motifs that occur in 59 UTRs. Statistical significance for the results obtained was calculated using Fisher's exact test for count data. Luciferase assays. Four tandem repeats of the (CGG) 4 12-nucleotide motif (GQs) or random sequence matched for length and GC content (random) were cloned into the 59 UTR of Renilla luciferase plasmid pGL4.73. Empty Firefly luciferase plasmid pGL4.13 or HCV-IRES Firefly were used as internal controls. Luciferase assays were performed using Dual-Luciferase Reporter Assay System (Promega E1960) following the manufacturer's instructions.
GQ sequences were as follows (in bold): CTAGGTTGAAAGTACTTTGACG GCGGCGGCGGTCAATCTTACGGCGGCGGCGGACATAGATACGGCGGC GGCGGTAGAAACTACGGCGGCGGCGGATTAGAATAGTAAA. Random sequence matched for GC content: CTAGGGCGCACGTACTTCGACAACGTCAG CGTTCAGCGTTCCAACGTCAGCGTACAGCGATCCAACGTCAGCGTTCTG CGCTACAACGTCAGCGTATCCGCGTAGCACA. Circular dichroism and thermal denaturation analysis. RNA oligonucleotides (see Supplementary Table 5 ) were used at 10 mM concentration. The buffer used for GQ studies contained 40 mM KCl, 10 mM potassium phosphate, pH 7.0 (ref. 50). The buffer used for salt-free conditions contained 10 mM sodium phosphate buffer pH 7.0. The circular dichroism experiments were performed using an Aviv 202 CD Spec (DWB 208) spectropolarimeter equipped with Peltier temperature control. For wavelength scan, a range of 320-220 nm was used with an equilibration time of 0.83 s. Thermal unfolding/folding experiments were performed across a temperature ARTICLE RESEARCH range of 15 uC to 95 uC, with a 1 uC per minute temperature gradient. At least five scans for each sample were collected and were corrected with respective buffer controls. Calculations for T m and DG were performed as described previously 51 .
Smoothing of the circular dichroism curves was performed with Prism software by cumulating five neighbouring data points. T-ALL samples. Thirty-six bone marrow biopsies were historically collected from patients with T-ALL at multiple organizations (Universitair Ziekenhuis (UZ) Ghent; UZ Leuven; Hôpital Purpan; Centre Hospitalier Universitaire de Nancy-Brabois). The QIAamp DNA Mini kit was used to obtain genomic DNA (Qiagen 51304). The Medical Ethical Commission of Ghent University Hospital (B67020084745) approved this study. Mutation analysis. NOTCH1 (exons 26, 27, 28 and 34), FBXW7 (exons 7, 8, 9, 10 and 11), PTEN (exons 1 till 9) and IL7R (exon 6) were amplified and sequenced using primers as reported previously [52] [53] [54] . FBXW7, PTEN and IL7R amplification were performed using 20 ng of genomic DNA, 13 KapaTaq reaction buffer (Kapa-Biosystems), 1 U KapaTaq DNA polymerase, 0.2 mM dNTP, 2.5 mM MgCl 2 , 0.2 mM forward and reverse primer in a 25 ml PCR reaction. For NOTCH1 amplification, we used the PCRx enhancer system (Invitrogen) for the PCR reaction. Reactions contained 20 ng of DNA, 2.5 U KapaTaq DNA Polymerase, 13 PCRx Amplification Buffer, 23 PCRx Enhancer Solution, 0.2 mM dNTP, 1.5 mM MgSO4 and 0.2 mM of each primer. The PCR steps were as follows: 95 uC for 10 min (96 uC for 15 s, 57 uC for 1 min, then 72 uC for 1 min) for 40 cycles, and then 72 uC for 10 min. Purified PCR products were analysed using the Applied Biosystems 3730XL DNA Analyse. Array complete genomic hybridization. PTEN deletions were detected by array complete genomic hybridization (CGH) analysis using SurePrint G3 Human 4x180K CGH Microarrays (Agilent Technologies). First, random prime labelling of the T-ALL DNA sample and a control human reference DNA was performed with Cy3 and Cy5 dyes (Perkin Elmer), respectively. The subsequent hybridization protocol was performed according to the manufacturer's instructions (Agilent Technologies). The data were analysed using arrayCGHbase 55 . Generation of mice. The ICN-driven mouse T-ALL model has been previously reported 1,20 . Mice were C57BL/6J females between 6 and 10 weeks of age. Treatment conditions and HPC genotypes were randomized and non-blinded; n was determined empirically based on previous mouse experiments. Data were analysed in Kaplan-Meier format using the log-rank (Mantel-Cox) test for statistical significance. The surface marker analysis was as described previously 1 . shRNAs against PTEN 52 and eIF4A1 (ref. 56 ) have been reported. For xenograft studies, 5,000,000 KOPT-K1 cells in 30% matrigel (BD 354234) were injected subcutaneously into C.B-17 SCID mice. When tumours were readily visible, the mice were injected on 7 consecutive days with 0.5 mg kg 21 silvestrol, 0.2 mg kg 21 (6)-CR-31-B, or vehicle control. Tumour size was measured daily by calliper. P values were calculated using two-way repeated measures ANOVA. All animal experiments were performed in accordance with regulations from Memorial Sloan-Kettering Cancer Center's Institutional Animal Care and Use Committee. T-ALL cell lines. T-ALL cell lines were obtained from ATCC and all tested negative for mycoplasma contamination. Lines were cultured in RPMI-1640 (Invitrogen), 20% fetal calf serum, 1% penicillin/streptomycin, and 1% L-glutamine. The MOHITO line was supplemented with 5 ng ml 21 IL2 (Fitzgerald 30R-AI022) and 10 ng ml 21 of IL7 (Fitzgerald 30R-AI084X). To generate IC 50 curves, T-ALL cell lines and samples were treated with silvestrol or (6)-CR-31-B for 48 h. Viable cells were measured using ATP quantification via the CellTiter-Glo Luminescent Cell Viability Assay (Promega G7571). Immunoblots. Lysates were made using Laemli lysis buffer. Thirty micrograms of protein was loaded onto SDS-PAGE gels then transferred onto Immobilon-FL Transfer Membranes (Millipore, IPFL00010). The antibodies used were a-tubulin (Sigma, T5168), b-actin (Sigma, A5316), MYC (Santa Cruz Biotechnology, sc-40), p-AKT 308 (Cell Signaling, 9275), AKT (Cell Signaling, 9272), S6 (Cell Signaling, 2317), p-S6 (Cell Signaling, 2215), NOTCH1 (Cell Signaling, 3608), MYB (Santa Cruz Biotechnology, sc-517), CDK6 (Cell Signaling, 3136), EZH2 (Cell Signaling, 5246), MDM2 (Santa Cruz Biotechnology, sc-965), CCND3 (Cell Signaling, 2936), BCL2 (Santa Cruz Biotechnology, sc-509), RUNX1 (Cell Signaling, 4336), and GAPDH (Cell Signaling, 5174). Statistical analysis. All Kaplan-Meier curves were analysed using the Mantel-Cox test. The significance of xenografted tumour size differences was determined using two-way repeated measures ANOVA tests. The significance of motif enrichments was determined using a one-tailed binomial test with correction for differences in 59 UTR lengths. The P value for this test is defined as Toxicity studies. Eight-week-oldC57BL/6NTac female mice were randomly assigned to either control or treatment groups. Each treatment group received one daily dose of test article through i.p. injections over 5 consecutive days. Toxicity was monitored by weight loss and daily clinical observation for the 14 days following test article administration. Twenty-four hours after the last test article administration, four mice in each group were killed and clinical chemistry, haematology and tissue specific histopathology were done at autopsy. The remaining mice (n 5 2 per group) were kept under observation for an additional 13 days; at that point all mice were killed and clinical chemistry, haematology and tissue-specific histopathology were done at time of autopsy.
